Insider Selling: Outset Medical, Inc. (NASDAQ:OM) CEO Sells 33,227 Shares of Stock

Outset Medical, Inc. (NASDAQ:OM) CEO Leslie Trigg sold 33,227 shares of the firm’s stock in a transaction on Monday, January 13th. The stock was sold at an average price of $0.81, for a total transaction of $26,913.87. Following the sale, the chief executive officer now owns 861,397 shares in the company, valued at approximately $697,731.57. The trade was a 3.71 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Leslie Trigg also recently made the following trade(s):

• On Tuesday, January 7th, Leslie Trigg sold 10,227 shares of Outset Medical stock. The stock was sold at an average price of $1.29, for a total value of $13,192.83.
• On Friday, November 15th, Leslie Trigg sold 5,645 shares of Outset Medical stock. The shares were sold at an average price of $0.80, for a total value of $4,516.00.

Outset Medical Stock Up 0.5 %

Outset Medical stock opened at $0.81 on Wednesday. The company has a current ratio of 6.49, a quick ratio of 5.04 and a debt-to-equity ratio of 4.12. Outset Medical, Inc. has a 1-year low of $0.44 and a 1-year high of $5.22. The company has a fifty day simple moving average of $1.01 and a 200 day simple moving average of $1.39. The company has a market cap of $42.67 million, a P/E ratio of -0.29 and a beta of 2.05.

Wall Street Analysts Forecast Growth

Separately, Royal Bank of Canada reiterated a “sector perform” rating and set a $3.00 price objective on shares of Outset Medical in a report on Tuesday, January 7th.

Hedge Funds Weigh In On Outset Medical

Several hedge funds have recently modified their holdings of the stock. National Bank of Canada FI raised its holdings in Outset Medical by 79.2% during the third quarter. National Bank of Canada FI now owns 52,407 shares of the company’s stock worth $35,000 after acquiring an additional 23,164 shares in the last quarter. Huntington National Bank increased its position in shares of Outset Medical by 46.2% during the 3rd quarter. Huntington National Bank now owns 63,306 shares of the company’s stock worth $43,000 after purchasing an additional 20,000 shares during the last quarter. Vanguard Personalized Indexing Management LLC bought a new stake in shares of Outset Medical during the 2nd quarter worth approximately $49,000. Point72 Asia Singapore Pte. Ltd. acquired a new stake in shares of Outset Medical in the 2nd quarter valued at approximately $259,000. Finally, Squarepoint Ops LLC grew its stake in shares of Outset Medical by 74.1% in the second quarter. Squarepoint Ops LLC now owns 80,300 shares of the company’s stock valued at $309,000 after buying an additional 34,187 shares in the last quarter.

About Outset Medical

Outset Medical, Inc, a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables.